期刊文献+

肿瘤坏死因子相关凋亡诱导配体对非小细胞肺癌细胞凋亡的诱导作用及其机制 被引量:7

Induction of tumor necrosis factor related apoptosis-inducing ligand of apoptosis of non-small cell lung carcinoma cells and its mechanism
下载PDF
导出
摘要 目的:探讨肿瘤坏死因子相关凋亡诱导配体(TRAIL)诱导人非小细胞肺癌H596细胞发生凋亡,初步阐明非小细胞肺癌细胞经TRAIL诱导凋亡的作用和机制。方法:培养H596细胞,设对照组和不同浓度(0.01、0.03、0.10、0.30、1.00、3.00、10.00、30.00和100.00μg.L-1)TRAIL组,TRAIL作用H596细胞24h后,酸性磷酸酶法检测细胞凋亡的百分率;Western blotting法检测TRAIL相关蛋白caspase-8、Bcl-2及Fas相关死亡结构域(FADD)的表达情况。结果:TRAIL浓度为0.01~0.03μg.L-1时,对H596细胞的生长无明显抑制作用,细胞出现增殖趋势;从0.10μg.L-1开始,随着TRAIL浓度升高,细胞开始出现凋亡,至10.00μg.L-1时细胞凋亡水平显著增加,与对照组比较差异有统计学意义(P<0.05)。Western blotting检测,caspase-8、Bcl-2和FADD蛋白表达正常。结论:高浓度的TRAIL可以诱导H596细胞发生凋亡,可能与TRAIL相关蛋白表达正常有关联。 Objective To study the apoptosis induced by tumor necrosis factor related apoptosis-inducing ligand (TRAIL) in non-small cell lung carcinoma H596 cells, and to explore the role and mechanism of apoptosis. Methods Non-small cell lung carcinoma H596 cells were cultivated, and acid phosphate assay was used to detect the apoptotic rate, and the expressions of caspase-8, Bcl-2 and Fas-associated death domain (FADD) proteins were detected by Western blotting in H596 cells. Results The apoptotic rates of H596 cells were decreased after the cells were treated with 0.01--0.03 μg L-1 TRAIL, and from 0.10 μg L-1 TRAIL, the apoptotic rates were increased; the differences in apoptotic rates of H596 cells after treated with 10.00--100.00 μg L-1 TRAIL were significant compared with control group (P〈0.05). The Western blotting results showed that the expressions of caspase-8, Bcl-2, FADD proteins were normal. Oonclusion High dose of TRAIL can induce apoptosis in H596 cells, and it may be related to the normal expressions of TRAIL related proteins.
出处 《吉林大学学报(医学版)》 CAS CSCD 北大核心 2013年第1期16-18,共3页 Journal of Jilin University:Medicine Edition
基金 国家自然科学基金资助课题(81201671) 吉林省教育厅项目资助课题(2012330 2012491)
关键词 非小细胞肺 肿瘤坏死因子相关凋亡诱导配体 细胞凋亡 carcinoma, non-small cell lung tumor necrosis factor related apoptosis-inducing ligand apoptosis
  • 相关文献

参考文献12

  • 1Bellail AC,Qi L,Mulligan P,et al.TRAIL agonists onclinical trials for cancer therapy:the promises and thechallenges[J].Rev Recent Clin Trials(Online),2009,4(1):34-41.
  • 2王爽,齐玲,金宏,张以忠,曹志友.肿瘤坏死因子相关凋亡诱导配体联合化疗药物对非小细胞肺癌细胞的作用机制研究[J].中国实验诊断学,2011,15(6):1000-1001. 被引量:4
  • 3齐玲,于洪泉,金宏,丁丽娟,温娜,唐泽波,李蕴潜.caspase-8在胶质母细胞瘤抵抗TRAIL诱导凋亡中的作用[J].吉林大学学报(医学版),2011,37(4):612-616. 被引量:9
  • 4南栗岩,齐玲,肖振晶,赵庆旭,王伟,于洪泉.原代培养的恶性胶质瘤细胞表达死亡受体与TRAIL抵抗的关系[J].中国老年学杂志,2011,31(18):3591-3592. 被引量:6
  • 5Walczak H,Miller RE,Ariail K,et al.Tumoricidal activityof tumor necrosis factor-related apoptosis-inducing ligand invivo[J].Nat Med,1999,5(2):157-163.
  • 6Ashkenazi A.Targeting death and decoy receptors of thetumour-necrosis factor superfamily[J].Nat Rev Cancer,2002,2(6):420-430.
  • 7Schneider P,Thome M,Burns K,et al.TRAIL receptors 1(DR4)and 2(DR5)signal FADD-dependent apoptosis andactivate NF-kappa B[J].Immunity,1997,12(7):831-836.
  • 8Kischkel FC,Lawrence DA,Chuntharapai A,et al.Apo2L/TRAIL-dependent recruitment of endogenous FADDand caspase-8to death receptors 4and 5[J].Immunity,2000,12(6):611-620.
  • 9Bellail AC,Tse MC,Song JH,et al.DR5-mediated DISCcontrols caspase-8cleavage and initiation of apoptosis in humanglioblastomas[J].J Cell Mol Med,2010,14(6A):1303-1317.
  • 10Reed JC.Bcl-2 family proteins[J].Oncogene,1998,17(25):3225-3236.

二级参考文献27

  • 1冯长根,周汉生,唐艳平,沈滟.rsTRAIL诱导人肺癌细胞系A549的细胞凋亡表达谱变化研究[J].中国药学杂志,2006,41(9):675-678. 被引量:4
  • 2Bellail AC, Qi L, Mulligan P, et al. TRAIL agonists on clinical trials for cancer therapy:the promises and the challenges [J]. Rev Recent Clin Trials ,2009 ;4( 1 ) :34-41.
  • 3Sathomsumetee S, Reardon DA, Desjardins A, et al. Molecularly targeted therapy for malignant glioma[J]. Cancer,2007 ; 110( 1 ) : 13-24.
  • 4Bellail A, Tse MC, Song JH, et al. DR5-mediated DISC controls caspase-8 cleavage and initiation of apoptosis in human glioblastomas[J].J Cell Mol Med ,2010 ; 14 (6A) : 1303-17.
  • 5Xiao C, Yang BF, Asadi N, et al. Tumor necrosis factor-related apoptosis- inducing ligand-induced death-inducing signaling complex and its modulation by c-FLIP and PED/PEA-15 in glioma cells [J]. J Biol Chem, 2002 ; 277 ( 28 ) : 25020 -5.
  • 6Song JH, Bellail A, Tse MC, et al. Human astrocytes are resistant to Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis[J]. J Neurosci ,2006 ;26 (12) :3299-308.
  • 7Griffith TS, Anderson RD, Davidson BL, et al. Adenoviral-mediated transfer of the TNF-related apoptosis-inducing ligand/Apo-2 ligand gene induces tumor cell apoptosis[J]. J Immunol,2000 ; 165 ( 5 ) :2886-94.
  • 8Almasan A, Ashkenazi A. Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy[J].Cytokine Growth Factor Rev,2003 ; 14(3-4) :337-48.
  • 9Jin H, Yang R, Fong S, et al. Apo2 apoptosis-inducing ligand cooperates topic lung tumor growth and improve ligand/tumor necrosis factor-related with chemotherapy to inhibit ortho- survival [ J ]. Cancer Res, 2004,64 :4900.
  • 10Anita C, Ling Qi, Patrick Mulligan, et al. TRAIL Agonists on Clinical Tri- als for Cancer Therapy:The Promises and the Challenges[J]. Reviews on Recent Clinical Trials(Online) ,2009, (4) :34.

共引文献13

同被引文献50

引证文献7

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部